CoChat

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021

Open access
Martínez-Baz, Iván, Trobajo-Sanmartín, Camino, Miqueleiz, Ana, Guevara, Marcela, Fernández-Huerta, Miguel, Burgui, Cristina, Casado, Itziar, Portillo, María Eugenia, Navascués, Ana, Ezpeleta, Carmen, Castilla, Jesús, the Working Group for the Study of COVID-19 in Navarre · 2021 · Eurosurveillance
Cited by 74

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

COVID-19 vaccine effectiveness by product (two doses Comirnaty, Spikevax or Vaxzevria and one of Janssen), against infection ranged from 50% (95% CI: 42 to 57) for Janssen to 86% (70 to 93) for Vaxzevria-Comirnaty combination; among ≥ 60 year-olds, from 17% (−26 to 45) for Janssen to 68% (48 to 80) for Spikevax; and against hospitalisation from 74% (43 to 88) for Janssen to > 90% for other products. Two doses of vaccine were highly effective against hospitalisation, but suboptimal for infection control.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2807/1560-7917.es.2021.26.39.2100894

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 74

Metadata

Authors
Martínez-Baz, I., Trobajo-Sanmartín, C., Miqueleiz, A., Guevara, M., Fernández-Huerta, M., Burgui, C., Casado, I., Portillo, M. E., Navascués, A., Ezpeleta, C., Castilla, J., & the Working Group for the Study of COVID-19 in Navarre
Venue
Eurosurveillance
Published
2021-09-30
Volume
26
Issue
39
ISSN
  • 1025-496X (ISSN-L)
  • 1560-7917
OpenAlex
W3203758403
Cited by
74
References
8
FWCI
4.96
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021. https://app.cochat.ai/papers/10.2807/1560-7917.es.2021.26.39.2100894
The paper
Martínez-Baz, I., Trobajo-Sanmartín, C., Miqueleiz, A., Guevara, M., Fernández-Huerta, M., Burgui, C., Casado, I., Portillo, M. E., Navascués, A., Ezpeleta, C., Castilla, J., & the Working Group for the Study of COVID-19 in Navarre. (2021). Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021. Eurosurveillance. https://doi.org/10.2807/1560-7917.es.2021.26.39.2100894

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.